3.1 The importation of pharmaceutical products should be effected in conformity with regulations promulgated under the national drugs act or other relevant legislation and enforced by the national drug regulatory authority. National guidelines providing recommendations on the implementation of these regulations should be drawn up by the national drug regulatory authority in collaboration with the customs authority and other interested agencies and organizations.
3.2 All transactions relating to the importation of consignments of pharmaceutical products should be conducted either through the governmental drug procurement agency or through independent wholesale dealers specifically designated and licensed by the national drug regulatory authority for this purpose.
3.3 The importation of all consignments of pharmaceutical products should be channelled exclusively through customs posts specifically designated for this purpose.
3.4 All formalities undertaken on importation should be coordinated by the customs service, which should have the authority to request the services of an official pharmaceutical inspector as occasion demands. When justified by the workload, a pharmaceutical inspector may be stationed full time at one or more of the designated ports of entry.
3.5 The customs authority should have the discretionary powers to request technical advice and opinions from other appropriately qualified persons, should this be warranted by particular circumstances.